Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/1998
08/27/1998WO1998037093A2 Compounds for immunotherapy of prostate cancer and methods for their use
08/27/1998WO1998037091A2 Modified retinoblastoma tumor suppressor proteins
08/27/1998WO1998037090A1 Antipathogenic synthetic peptides and compositions comprising them
08/27/1998WO1998037087A1 Inhibition of major groove dna binding proteins by modified polyamides
08/27/1998WO1998037067A1 Design, synthesis and use of specific polyamide dna-binding ligands
08/27/1998WO1998037066A1 Improved polyamides for binding in the minor groove of double stranded dna
08/27/1998WO1998036774A1 Method of treating a lactate dehydrogenase-a (ldh-a)-associated disorder
08/27/1998WO1998036773A1 Therapeutic uses for antioxidants
08/27/1998WO1998036771A1 Method for the production of vaccines against cell surface proteins
08/27/1998WO1998036770A1 Preparations for the treatment of metabolic syndrome containing human growth hormone in combination with a cortisol synthesis inhibitor
08/27/1998WO1998036769A1 Pulsatile delivery of leptin receptor ligands
08/27/1998WO1998036768A1 Use of interleukin-15
08/27/1998WO1998036767A1 Modulation of the hypothalamic-pituitary-adrenal-adipose axis with leptin receptor ligands
08/27/1998WO1998036766A1 Anti-hiv protein
08/27/1998WO1998036765A1 Isolation and structural elucidation of the cytostatic linear and cyclo-depsipeptides dolastatin 16, dolastatin 17, and dolastatin 18
08/27/1998WO1998036764A2 Method of treating psychological and metabolic disorders using igf or igf/igfbp-3
08/27/1998WO1998036763A1 Treatment of infertility with leptin receptor ligands
08/27/1998WO1998036762A1 Method of modulating hypothalamic somatostatin release
08/27/1998WO1998036743A1 Neuroprotective poly-guanidino compounds which block presynaptic n and p/q calcium channels
08/27/1998WO1998036736A1 Pharmaceutical preparation comprising lyophilized liposomes encapsulating an active principle which is highly insoluble in water, and the process for preparing the said preparation
08/27/1998WO1998036734A1 A novel nutritional therapy which minimizes plasma cholecystokinin (cck) levels
08/27/1998WO1998036705A1 Augmentation and repair of dermal, subcutaneous, and vocal cord tissue defects
08/27/1998WO1998036704A1 Augmentation and repair of dermal, subcutaneous, and vocal cord tissue defects
08/27/1998WO1998036641A1 Control of il4 production as a therapeutic regulator of immune function
08/27/1998WO1998028419A3 Methods and compositions for modulation of vesicular release
08/27/1998WO1998025640A3 Novel methods for testing inhibitors of paired helical filaments and uses for treatment of alzheimer's disease
08/27/1998WO1998022140A3 Hybrid compositions for intracellular targeting
08/27/1998WO1998010786A3 Pharmaceutical composition for the treatment of syndrome x of reaven
08/27/1998WO1998006437A3 Compositions and methods for polynucleotide delivery
08/27/1998DE19708454A1 Die Proliferation von Zellen inhibierendes Peptid und dessen Verwendung The proliferation of cells inhibiting peptide and use thereof
08/27/1998DE19705924A1 Use of N-(3,5-dichloropyrid-4-yl)-3-cyclopropymethoxy-4- difluoromethoxybenzamide
08/27/1998CA2742641A1 Compounds for immunotherapy of prostate cancer and methods for their use
08/27/1998CA2283090A1 Method for induction of apoptotic cell death in malignant cells, through reduction of the rb to apoptosis inducing proteins ratio
08/27/1998CA2282859A1 Method for the production of vaccines against cell surface proteins
08/27/1998CA2282504A1 Isolation and structural elucidation of the cytostatic linear and cyclo-depsipeptides dolastatin 16, dolastatin 17, and dolastatin 18
08/27/1998CA2282467A1 Preparations for the treatment of metabolic syndrome containing human growth hormone in combination with a cortisol synthesis inhibitor
08/27/1998CA2282414A1 Oviductal catalase binding to the membranes of spermatozoa and uses thereof
08/27/1998CA2282341A1 Modulation of the hypothalamic-pituitary-adrenal-adipose axis with leptin receptor ligands
08/27/1998CA2282325A1 Pulsatile delivery of leptin receptor ligands
08/27/1998CA2282323A1 Method of modulating hypothalamic somatostatin release
08/27/1998CA2282302A1 Morphogenic proteins
08/27/1998CA2281949A1 Transgenically produced non-secreted proteins
08/27/1998CA2281948A1 Inhibition of major groove dna binding proteins by modified polyamides
08/27/1998CA2281947A1 Improved polyamides for binding in the minor groove of double stranded dna
08/27/1998CA2281930A1 Design, synthesis and use of specific polyamide dna-binding ligands
08/27/1998CA2281912A1 Therapeutic use of the smr1 protein and active derivatives thereof
08/27/1998CA2281899A1 Modified retinoblastoma tumor suppressor proteins
08/27/1998CA2281893A1 Gamma-1 and gamma-3 anti-human cd23 monoclonal antibodies and use thereof as therapeutics
08/27/1998CA2281890A1 Method of treating psychological and metabolic disorders using igf or igf/igfbp-3
08/27/1998CA2281888A1 Treatment of infertility with leptin receptor ligands
08/27/1998CA2281794A1 Antibody fragment-polymer conjugates and humanized anti-il-8 monoclonal antibodies
08/27/1998CA2281674A1 Parg, a gtpase activating protein which interacts with ptpl1
08/27/1998CA2281669A1 Human sodium-dependent phosphate cotransporter
08/27/1998CA2281204A1 Antipathogenic synthetic peptides and compositions comprising them
08/27/1998CA2281059A1 Secreted proteins and polynucleotides encoding them
08/27/1998CA2251645A1 Eukaryotic cells expressing at their surface at least an hla-g isoform and their applications
08/26/1998EP0860700A2 Use of HSV-1 UL-15 and VP5 in identifying anti-viral agents
08/26/1998EP0860506A1 Human protein kinase hYAKI (HOACF 72)
08/26/1998EP0860504A1 Polypeptides of feline T-cell lymphotropic lentivirus
08/26/1998EP0860502A1 cDNA clone HDPBI30 that encodes a novel human 7-transmembrane receptor
08/26/1998EP0860501A2 Corticotropin-releasing factor2 receptors
08/26/1998EP0860447A1 Hematopoietic stem cell growth factor (scgf)
08/26/1998EP0860446A1 Type cc chemokine-like protein
08/26/1998EP0859860A1 Diagnosis of susceptibility to cancer and treatment thereof
08/26/1998EP0859854A1 Retroviral vectors carrying senescent cell derived inhibitors 1 (sdi-1) or antisense sdi-1 nucleotide sequences
08/26/1998EP0859847A1 Composition and method of imparting resistivity to hiv superinfection to cells
08/26/1998EP0859845A1 Novel cell surface protein compounds
08/26/1998EP0859844A1 Interleuken-3 (il-3) receptor agonists
08/26/1998EP0859843A1 Novel g-csf receptor agonists
08/26/1998EP0859842A1 SHORT FORMS OF CHEMOKINE $g(b)-8
08/26/1998EP0859840A1 Biologically active eph family ligands
08/26/1998EP0859839A1 ACTIVATION OF p53 PROTEIN
08/26/1998EP0859838A1 Novel procollagens
08/26/1998EP0859837A2 Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor
08/26/1998EP0859834A2 A paf-acetylhydrolase and use in therapy
08/26/1998EP0859830A2 Growth of adult pancreatic islet cells with laminin 5
08/26/1998EP0859789A1 Hemoglobin mutants that reduce heme loss
08/26/1998EP0859787A1 G-protein coupled receptor hnfds78
08/26/1998EP0859786A1 Peptide derivatives of dolastatin 15 and their use
08/26/1998EP0859785A1 Cyclic peptide analogs of somatostatin
08/26/1998EP0859784A1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation
08/26/1998EP0859783A1 Process for isolating immunoglobulins in whey
08/26/1998EP0859640A1 Method for restoring glucose responsiveness to insulin secretion
08/26/1998EP0859639A1 Methods for treating cancers and restenosis with p21
08/26/1998EP0859638A1 Method for inhibiting cell-mediated killing of target cells
08/26/1998EP0859637A1 Compositions for the treatment and diagnosis of body weight disorders, including obesity
08/26/1998EP0859636A1 Hyaluronic acid as dna carrier for gene therapy and vegf antisense dna to treat abnormal retinal vascularization
08/26/1998EP0859633A2 Method for treating diabetes
08/26/1998EP0859631A1 Treatment or prevention of neoplastic and infectious diseases with heat shock/stress proteins
08/26/1998EP0859630A1 Combination of temozolomide and alpha-ifn for the treatment of advanced cancer
08/26/1998EP0859629A2 Product for inhibition of attachment of h. influenzae to human cells
08/26/1998EP0859628A1 Drug, in particular for modulating the immunological response for the control of viruses, tumours, bacteria and parasites
08/26/1998EP0859627A1 Mimicking peptides in cancer therapy
08/26/1998EP0859626A1 Pharmaceutical preparation containing cyclosporin(s) for oral administration and process for producing the said preparation
08/26/1998EP0859625A1 Composition and methods for enhancing immune responses mediated by antigen-presenting cells
08/26/1998EP0859624A1 GnRH/REDUCED PSEUDOMONAS EXOTOXIN CONJUGATES
08/26/1998EP0859622A1 Extracts of shark cartilage
08/26/1998EP0859611A1 Enhancement of erectile function with renin-angiotensin system inhibitors
08/26/1998EP0859608A1 Treating niddm with rxr agonists
08/26/1998EP0859606A1 Buccal delivery of glucagon-like insulinotropic peptides
1 ... 2597 2598 2599 2600 2601 2602 2603 2604 2605 2606 2607 2608 2609 2610 2611 2612 2613 2614 2615 2616 2617 ... 3163